We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

XTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review

Published: March 2019
Pages: 25
Code: 01E3DD14976033939A10F5B603C3AE64
Format: PDF
Publisher GlobalData
From Add to basket
$ 300.00
XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin. Its hCDR1 peptide is used for the treatment of systemic lupus erythematosus. XTL’s recombinant human erythropoietin is a compound developed for the prolongation of multiple myeloma advanced-stage patients’ survival and is used in clinical practice for the treatment of various anemias including anemia of kidney disease and cancer-related anemia. The company’s pipeline is generated by identifying, validating and in-licensing therapeutic candidates. XTL is headquartered in Ra'anana, Israel.
XTL Biopharmaceuticals Ltd Key Recent Developments
May 29,2018: XTL Biopharmaceuticals Reports First Quarter 2018 Financial Results & Provides Update
This comprehensive SWOT profile of XTL Biopharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of XTL Biopharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
  • Table of Contents
  • Section 1 - About the Company
  • XTL Biopharmaceuticals Ltd - Key Information
  • XTL Biopharmaceuticals Ltd - Overview
  • XTL Biopharmaceuticals Ltd - Key Employees
  • XTL Biopharmaceuticals Ltd - Key Employee Biographies
  • XTL Biopharmaceuticals Ltd - Key Operational Heads
  • XTL Biopharmaceuticals Ltd - Major Products and Services
  • XTL Biopharmaceuticals Ltd - History
  • XTL Biopharmaceuticals Ltd - Company Statement
  • XTL Biopharmaceuticals Ltd - Locations And Subsidiaries
  • XTL Biopharmaceuticals Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
  • Section 2 - Company Analysis
  • XTL Biopharmaceuticals Ltd - Business Description
  • XTL Biopharmaceuticals Ltd - Corporate Strategy
  • XTL Biopharmaceuticals Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • XTL Biopharmaceuticals Ltd - Strengths
  • XTL Biopharmaceuticals Ltd - Weaknesses
  • XTL Biopharmaceuticals Ltd - Opportunities
  • XTL Biopharmaceuticals Ltd - Threats
  • XTL Biopharmaceuticals Ltd - Key Competitors
  • Section 3 - Company Financial Performance Charts
  • XTL Biopharmaceuticals Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Note*: Some sections may be missing if data is unavailable for the company
  • List of Tables
  • XTL Biopharmaceuticals Ltd, Key Information
  • XTL Biopharmaceuticals Ltd, Key Ratios
  • XTL Biopharmaceuticals Ltd, Share Data
  • XTL Biopharmaceuticals Ltd, Major Products and Services
  • XTL Biopharmaceuticals Ltd, History
  • XTL Biopharmaceuticals Ltd, Key Employees
  • XTL Biopharmaceuticals Ltd, Key Employee Biographies
  • XTL Biopharmaceuticals Ltd, Key Operational Heads
  • XTL Biopharmaceuticals Ltd, Other Locations
  • XTL Biopharmaceuticals Ltd, Subsidiaries
  • XTL Biopharmaceuticals Ltd, Key Manufacturing facilities
  • XTL Biopharmaceuticals Ltd, Key Competitors
  • XTL Biopharmaceuticals Ltd, SWOT Analysis
  • XTL Biopharmaceuticals Ltd, Ratios based on current share price
  • XTL Biopharmaceuticals Ltd, Annual Ratios
  • XTL Biopharmaceuticals Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • XTL Biopharmaceuticals Ltd, Performance Chart
  • XTL Biopharmaceuticals Ltd, Ratio Charts